MYOVIEW 30ML
Google image searchProduct monograph
Active ingredient
tetrofosmin, 1.38 MG/VIAL
DIN: 02422158
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Schedule C
Company: GE HEALTHCARE CANADA INC
Date: 27-NOV-2018
ATC:
- V09 — DIAGNOSTIC RADIOPHARMACEUTICALS (ATC, ATC/DDD, )
- V09G — CARDIOVASCULAR SYSTEM (ATC, ATC/DDD)
- V09GA — Technetium (99mTc) compounds (ATC, ATC/DDD)
- V09GA02 — TECHNETIUM (99m Tc) TETROFOSMIN (ATC/DDD)
